Some Experts Urge Eradication of U.S., Russian Smallpox Stocks

Global Security Newswire Staff
Add to Briefcase
Global Security Newswire Staff
May 5, 2014, 9:06 a.m.

Ahead of a ma­jor glob­al pub­lic health meet­ing this month, a num­ber of ex­perts are ur­ging Wash­ing­ton and Mo­scow to des­troy their small­pox samples.

The health min­is­ters of coun­tries be­long­ing to the World Health Or­gan­iz­a­tion are slated to de­bate in Geneva, Switzer­land, wheth­er the United States and Rus­sia should be called on to elim­in­ate their strains of the live vari­ola vir­us. U.S. of­fi­cials ar­gue that the samples should be re­tained to per­mit more re­search on im­proved small­pox coun­ter­meas­ures. But some out­side ex­perts say the ma­ter­i­al is too dan­ger­ous to war­rant con­tin­ued re­ten­tion, the As­so­ci­ated Press re­por­ted on Sunday.

The World Health As­sembly, the gov­ern­ing body of the World Health Or­gan­iz­a­tion, has re­peatedly delayed es­tab­lish­ing a date for when the small­pox strains — the last known re­main­ing samples in the world of the deadly vir­us — should be des­troyed. En­hanced ver­sions of the small­pox vac­cine are cur­rently be­ing stock­piled. Mean­while, two an­ti­vir­al med­ic­a­tions for the vir­us are un­der de­vel­op­ment.

“We be­lieve that the small­pox re­search pro­gram is ef­fect­ively com­plete and the case for de­struc­tion is stronger than ever,” said Lim Li Ching, a biosafety ex­pert as­so­ci­ated with the Third World Net­work, which ad­voc­ates for des­troy­ing the small­pox strains in a two-year time­frame.

D.A. Hende­r­son, who pre­vi­ously headed the suc­cess­ful WHO cam­paign to erad­ic­ate small­pox from nature, told AP that re­tain­ing live samples is no longer sci­en­tific­ally war­ran­ted as the vir­us’ ge­net­ic code is already known.

“Let’s des­troy the vir­us and be done with it,” Hende­r­son said. “We would be bet­ter off spend­ing our money in bet­ter ways” such as on de­vel­op­ing en­hanced coun­ter­meas­ures for com­bat­ing oth­er dis­ease agents that could be used as bio­lo­gic­al weapons.

Through syn­thet­ic bio­logy, the small­pox vir­us could be man­u­fac­tured in a labor­at­ory if ne­ces­sary in or­der to de­vel­op new med­ic­al coun­ter­meas­ures, ex­perts say. However, the same tech­no­logy could be mis­used by bad act­ors look­ing to ac­quire small­pox for use in an act of bio­lo­gic­al ter­ror­ism.

“Syn­thet­ic bio­logy adds a new wrinkle to it,” U.S. Health and Hu­man Ser­vices As­sist­ant Sec­ret­ary for Glob­al Af­fairs Jimmy Kolk­er said in an in­ter­view. “We now aren’t as sure that our coun­ter­meas­ures are go­ing to be as ef­fect­ive as we’d thought even five years ago.”

What We're Following See More »
WWE WRESTLING OWNER
Trump to Nominate Linda McMahon to Head SBA
9 hours ago
THE LATEST
$6.3 BILLION FOR RESEARCH AND OPIOIDS
Senate Sends Medical Cures Bill to Obama’s Desk
14 hours ago
THE LATEST
HAD CONSIDERED RUNNING FOR GUV IN 2018
Oklahoma AG Pruitt to Get the Nod for EPA Chief
15 hours ago
THE DETAILS
TO BE ANNOUNCED IN COMING DAYS
Trump To Nominate Gen. John Kelly For Homeland Security
18 hours ago
THE LATEST

Donald Trump has chosen Gen. James Kelly to be his secretary of homeland security, making Kelly the third general tapped by Trump to serve in his administration. The official announcement is likely to come in the next couple of days. Kelly, who did not endorse Trump during the campaign, "was the commander of U.S. Southern Command until earlier this year."

Source:
EFFORT LIKELY TO DIE IN COMMITTEE
Jordan Can’t Force a Floor Vote on Impeaching Koskinen
1 days ago
THE LATEST
House Freedom Caucus Chairman Jim Jordan attempted to force a floor vote on impeaching IRS Commissioner John Koskinen, but "the House voted overwhelmingly to refer it to the Judiciary Committee. ... The committee will not be required to take up the resolution." Earlier, House Minority Leader Nancy Pelosi "made a motion to table the resolution, which the House voted against by a 180-235 margin, mostly along party lines."
Source:
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login